Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Central role of RAGE-dependent neointimal expansion in arterial restenosis
Taichi Sakaguchi, … , Ann Marie Schmidt, Yoshifumi Naka
Taichi Sakaguchi, … , Ann Marie Schmidt, Yoshifumi Naka
Published April 1, 2003
Citation Information: J Clin Invest. 2003;111(7):959-972. https://doi.org/10.1172/JCI17115.
View: Text | PDF
Article Cardiology Article has an altmetric score of 6

Central role of RAGE-dependent neointimal expansion in arterial restenosis

  • Text
  • PDF
Abstract

Cellular proliferation, migration, and expression of extracellular matrix proteins and MMPs contribute to neointimal formation upon vascular injury. Wild-type mice undergoing arterial endothelial denudation displayed striking upregulation of receptor for advanced glycation end products (RAGE) in the injured vessel, particularly in activated smooth muscle cells of the expanding neointima. In parallel, two of RAGE’s signal transducing ligands, advanced glycation end products (AGEs) and S100/calgranulins, demonstrated increased deposition/expression in the injured vessel wall. Blockade of RAGE, employing soluble truncated receptor or antibodies, or in homozygous RAGE null mice, resulted in significantly decreased neointimal expansion after arterial injury and decreased smooth muscle cell proliferation, migration, and expression of extracellular matrix proteins. A critical role for smooth muscle cell RAGE signaling was demonstrated in mice bearing a transgene encoding a RAGE cytosolic tail-deletion mutant, specifically in smooth muscle cells, driven by the SM22α promoter. Upon arterial injury, neointimal expansion was strikingly suppressed compared with that observed in wild-type littermates. Taken together, these data highlight key roles for RAGE in modulating smooth muscle cell properties after injury and suggest that RAGE is a logical target for suppression of untoward neointimal expansion consequent to arterial injury.

Authors

Taichi Sakaguchi, Shi Fang Yan, Shi Du Yan, Dmitri Belov, Ling Ling Rong, Monica Sousa, Martin Andrassy, Steven P. Marso, Stephan Duda, Bernd Arnold, Birgit Liliensiek, Peter P. Nawroth, David M. Stern, Ann Marie Schmidt, Yoshifumi Naka

×

Total citations by year

Year: 2025 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Total
Citations: 2 3 5 7 5 10 6 6 4 3 13 7 10 4 9 21 10 5 3 5 4 2 144
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (144)

Title and authors Publication Year
Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease
Li W, Chen Q, Peng C, Yang D, Liu S, Lv Y, Jiang L, Xu S, Huang L
International Journal of Molecular Sciences 2025
S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers
Mugisha S, Baba SA, Labhsetwar S, Dave D, Zakeri A, Klemke R, Desgrosellier JS
Oncogene 2025
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
Dozio E, Caldiroli L, Molinari P, Castellano G, Delfrate NW, Romanelli MM, Vettoretti S
Antioxidants 2023
A Role for Advanced Glycation End Products in Molecular Ageing
Zgutka K, Tkacz M, Tomasiak P, Tarnowski M
International journal of molecular sciences 2023
Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes
Bansal S, Burman A, Tripathi AK
World journal of diabetes 2023
Does AGE-RAGE Stress Play a Role in the Development of Coronary Artery Disease in Obesity?
Prasad K, Khan AS, Bhanumathy KK
International Journal of Angiology 2022
Bone matrix quality in a developing high-fat diet mouse model is altered by RAGE deletion
Stephen SJ, Bailey S, D\u2019Erminio DN, Krishnamoorthy D, Iatridis JC, Vashishth D
Bone 2022
Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
Lee J, Yun JS, Ko SH
Nutrients 2022
RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review
Faruqui T, Khan MS, Akhter Y, Khan S, Rafi Z, Saeed M, Han I, Choi EH, Yadav DK
International journal of molecular sciences 2022
Mechanism of Hypercholesterolemia-Induced Atherosclerosis
Prasad K, Mishra M
2022
AGE–RAGE Stress and Coronary Artery Disease
K Prasad
International Journal of Angiology 2021
Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
S Taneja, SW Vetter, E Leclerc
International journal of molecular sciences 2021
DIAPH1 Variants in Non–East Asian Patients With Sporadic Moyamoya Disease
AJ Kundishora, ST Peters, A Pinard, D Duran, S Panchagnula, T Barak, DF Miyagishima, W Dong, H Smith, J Ocken, A Dunbar, C Nelson-Williams, S Haider, RL Walker, B Li, H Zhao, D Thumkeo, A Marlier, PQ Duy, NS Diab, BC Reeves, SM Robert, N Sujijantarat, AN Stratman, YH Chen, S Zhao, I Roszko, Q Lu, B Zhang, S Mane, C Castaldi, F López-Giráldez, JR Knight, MJ Bamshad, DA Nickerson, DH Geschwind, SS Chen, PB Storm, ML Diluna, CC Matouk, DB Orbach, SL Alper, ER Smith, RP Lifton, M Gunel, DM Milewicz, SC Jin, KT Kahle
JAMA NEUROL 2021
Association between soluble forms of the receptor for advanced glycation end products and periodontal disease: a retrospective study.
Kim KS, Lee YJ, Ahn S, Chang YS, Choi Y, Lee HJ
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2021
Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice
Manigrasso MB, Rabbani P, Egaña-Gorroño L, Quadri N, Frye L, Zhou B, Reverdatto S, Ramirez LS, Dansereau S, Pan J, Li H, D\u2019Agati VD, Ramasamy R, DeVita RJ, Shekhtman A, Schmidt AM
Science Translational Medicine 2021
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease.
Molinari P, Caldiroli L, Dozio E, Rigolini R, Giubbilini P, Romanelli MMC, Messa P, Vettoretti S
2021
Satellite Cell Expression of RAGE (Receptor for Advanced Glycation end Products) Is Important for Collateral Vessel Formation.
Hansen L, Joseph G, Valdivia A, Taylor WR
Journal of the American Heart Association 2021
Multiomics of World Trade Center Particulate Matter–induced Persistent Airway Hyperreactivity. Role of Receptor for Advanced Glycation End Products
SH Haider, A Veerappan, G Crowley, EJ Caraher, D Ostrofsky, M Mikhail, R Lam, Y Wang, M Sunseri, S Kwon, DJ Prezant, M Liu, AM Schmidt, A Nolan
American journal of respiratory cell and molecular biology 2020
AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment
K Prasad, KK Bhanumathy
International Journal of Angiology 2020
Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort
Y Bauer, S de Bernard, P Hickey, K Ballard, J Cruz, P Cornelisse, H Chadha-Boreham, O Distler, D Rosenberg, M Doelberg, S Roux, O Nayler, A Lawrie
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2020
RAGE Signaling in Melanoma Tumors
OT Olaoba, S Kadasah, SW Vetter, E Leclerc
International journal of molecular sciences 2020
Vitamin D attenuates HMGB1-mediated neointimal hyperplasia after percutaneous coronary intervention in swine
M Satish, P Gunasekar, JA Asensio, DK Agrawal
Molecular and Cellular Biochemistry 2020
INOSITOL MONOPHOSPHATASE 1 (IMPA1) AS A NOVEL INTERACTING PARTNER OF RAGE IN PULMONARY HYPERTENSION
R Rafikov, ML McBride, M Zemskova, S Kurdyukov, N McClain, M Niihori, PR Langlais, O Rafikova
American journal of physiology. Lung cellular and molecular physiology 2019
Coalescence of RAGE in Lipid Rafts in Response to Cytolethal Distending Toxin-Induced Inflammation
HJ Lin, ZP Jiang, HR Lo, CL Feng, CJ Chen, CY Yang, MZ Huang, HY Wu, YA Chen, Y Chen, CH Chiu, CH Lai
Frontiers in immunology 2019
AGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease
K Prasad
Molecular and Cellular Biochemistry 2019
Soluble Forms of the Receptor for Advanced Glycation Endproducts (RAGE) in Periodontitis
L Detzen, B Cheng, CY Chen, PN Papapanou, E Lalla
Scientific Reports 2019
AGE–RAGE Stress in the Pathophysiology of Pulmonary Hypertension and its Treatment
K Prasad
International Journal of Angiology 2019
The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease
X Wang, T Xu, D Mungun, C Zhou, Z Zha, M Lu, C Fen, Y Guo
Disease Markers 2019
Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
DH Fernando, JM Forbes, PW Angus, CB Herath
International journal of molecular sciences 2019
Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness
J Gelžinský, O Mayer, J Seidlerová, M Mateřánková, Š Mareš, V Kordíková, L Trefil, R Cífková, J Filipovský
Hypertension Research 2019
AGE–RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment
K Prasad
International Journal of Angiology 2019
Pentosidine in chronic hemodialysis patients: relation with arteriovenous fistula morphology and function.
Ticala M, Tirinescu DC, Rusu CC, Moldovan D, Potra AR, Coman AL, Bondor CI, Budisan L, Kacsó IM
International Urology and Nephrology 2019
The receptor for advanced glycation end products (RAGE) and DIAPH1: unique mechanisms and healing the wounded vascular system
R Ramasamy, RA Friedman, A Shekhtman, AM Schmidt
Expert Review of Proteomics 2018
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus
N Katakami
Journal of Atherosclerosis and Thrombosis 2018
Deletion of the Formin, Diaph1, Protects from Structural and Functional Abnormalities in the Murine Diabetic Kidney
MB Manigrasso, RA Friedman, R Ramasamy, VD D'Agati, AM Schmidt
American journal of physiology. Renal physiology 2018
RAGE mediates Aβ accumulation in a mouse model of Alzheimer’s disease via modulation of β- and γ-secretase activity
F Fang, Q Yu, O Arancio, D Chen, SS Gore, SS Yan, SF Yan
Human Molecular Genetics 2018
The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function
L Hénaut, A Mary, JM Chillon, S Kamel, Z Massy
Toxins 2018
Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study
C Pearce, N Islam, R Bryce, E McNair
International Journal of Angiology 2018
AGE–RAGE Stress, Stressors, and Antistressors in Health and Disease
K Prasad, M Mishra
International Journal of Angiology 2017
Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells
AR Hwang, JH Han, JH Lim, YJ Kang, CH Woo, A Ahmad
PloS one 2017
Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: A case-cohort study and murine model of acute particulate exposure
EJ Caraher, S Kwon, SH Haider, G Crowley, A Lee, M Ebrahim, L Zhang, LC Chen, T Gordon, M Liu, DJ Prezant, AM Schmidt, A Nolan, H Fehrenbach
PloS one 2017
Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?
K Prasad, M Mishra
International Journal of Angiology 2017
Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
MH Baig, AT Jan, G Rabbani, K Ahmad, JM Ashraf, T Kim, HS Min, YH Lee, WK Cho, JY Ma, EJ Lee, I Choi
Scientific Reports 2017
Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study)
T Takayama, T Hiro, S Yoda, D Fukamachi, H Haruta, T Kogo, T Mineki, H Murata, T Oshima, A Hirayama
Heart and Vessels 2017
Atherosclerosis and the Hypercholesterolemic AGE–RAGE Axis
E McNair, M Qureshi, K Prasad, C Pearce
International Journal of Angiology 2016
The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice
LM Hansen, D Gupta, G Joseph, D Weiss, WR Taylor
Laboratory Investigation 2016
Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis
MJ Park, SH Lee, SJ Moon, JA Lee, EJ Lee, EK Kim, JS Park, J Lee, JK Min, SJ Kim, SH Park, ML Cho
Scientific Reports 2016
A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
N Petrasheskaya, HJ Tae, I Ahmet, MI Talan, EG Lakatta, L Lin
Journal of visualized experiments : JoVE 2016
The multiple faces of RAGE – opportunities for therapeutic intervention in aging and chronic disease
R Ramasamy, A Shekhtman, AM Schmidt
Expert Opinion on Therapeutic Targets 2015
Pathophysiology and Medical Treatment of Carotid Artery Stenosis
K Prasad
International Journal of Angiology 2015
S100A12 and the S100/CalgranulinsSignificance: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets
A Oesterle, MA Bowman
Arteriosclerosis, thrombosis, and vascular biology 2015
Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
J Song, W Lee, K Park, J Lee
International journal of molecular sciences 2014
Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury
H Zhang, Y Wang, S Yan, F Du, L Wu, S Yan, SS Yan
Cell Death and Disease 2014
The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach
P Salahuddin, G Rabbani, R Khan
Cellular & Molecular Biology Letters 2014
Mono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated with increased C/EBP homologous protein expression
RL Serrano, W Yu, R Terkeltaub
Atherosclerosis 2014
GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous expression in Chinese hamster ovary cells
W Wei, JM Kim, D Medina, EG Lakatta, L Lin
Protein Expression and Purification 2014
Vessel Ultrasound Sonographic Assessment of Soluble Receptor for Advanced Glycation End Products Efficacy in a Rat Balloon Injury Model
HJ Tae, N Petrashevskaya, I Ahmet, S Park, MI Talan, EG Lakatta, L Lin
Current Therapeutic Research 2014
Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells
BB Di, HW Li, WP Li, XH Shen, ZJ Sun, X Wu
Molecular medicine reports 2014
RAGE, Receptor of Advanced Glycation Endoproducts, Negatively Regulates Chondrocytes Differentiation
T Kosaka, R Fukui, M Matsui, Y Kurosaka, H Nishimura, M Tanabe, Y Takakura, K Iwai, T Waki, T Fujita, BI Hudson
PloS one 2014
Rapamune Does Not Attenuate High Cholesterol-Induced Atherosclerosis in Rabbits
A Attia, M Ahmed, S Ng, K Prasad, A Shoker
International Journal of Angiology 2014
RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma
X Chen, L Zhang, IY Zhang, J Liang, H Wang, M Ouyang, S Wu, AC da Fonseca, L Weng, Y Yamamoto, H Yamamoto, R Natarajan, B Badie
Cancer research 2014
S100/Calgranulin-Mediated Inflammation Accelerates Left Ventricular Hypertrophy and Aortic Valve Sclerosis in Chronic Kidney Disease in a Receptor for Advanced Glycation End Products-Dependent Manner
L Yan, L Mathew, B Chellan, B Gardner, J Earley, TS Puri, MA Bowman
Arteriosclerosis, thrombosis, and vascular biology 2014
Role of Advanced Glycation End Products and Its Receptors in the Pathogenesis of Cigarette Smoke-Induced Cardiovascular Disease
K Prasad, I Dhar, G Caspar-Bell
International Journal of Angiology 2014
Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts
Li DX, Deng TZ, Lv J, Ke J
Brazilian Journal of Medical and Biological Research 2014
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
YK Chuah, R Basir, H Talib, TH Tie, N Nordin
International Journal of Inflammation 2013
Advanced glycation end products: role in pathology of diabetic cardiomyopathy
VL Bodiga, SR Eda, S Bodiga
Heart Failure Reviews 2013
The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation
MA Bowman, AM Schmidt
Journal of Molecular Medicine 2013
The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth
HJ Tae, JM Kim, S Park, N Tomiya, G Li, W Wei, N Petrashevskaya, I Ahmet, J Pang, S Cruschwitz, RA Riebe, Y Zhang, CH Morrell, D Browe, YC Lee, R Xiao, MI Talan, EG Lakatta, L Lin
Journal of Molecular Medicine 2013
Increase of ADAM10 Level in Coronary Artery In-Stent Restenosis Segments in Diabetic Minipigs: High ADAM10 Expression Promoting Growth and Migration in Human Vascular Smooth Muscle Cells via Notch 1 and 3
K Yang, L Lu, Y Liu, Q Zhang, LJ Pu, LJ Wang, ZB Zhu, YN Wang, H Meng, XJ Zhang, R Du, QJ Chen, WF Shen, C Peiró
PloS one 2013
Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function
J Jules, D Maiguel, BI Hudson, TD Oury
PloS one 2013
Advanced Glycated End-Products Affect HIF-Transcriptional Activity in Renal Cells
T Bondeva, J Heinzig, C Ruhe, G Wolf
Molecular Endocrinology 2013
The Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative & Signal Transduction Pathways
F Touré, G Fritz, Q Li, V Rai, G Daffu, YS Zou, R Rosario, R Ramasamy, AS Alberts, SF Yan, AM Schmidt
Circulation research 2012
Diabetic Peripheral Neuropathy: Should a Chaperone Accompany Our Therapeutic Approach?
KL Farmer, C Li, RT Dobrowsky, EE Scott
Pharmacological reviews 2012
STAT3 signaling in pulmonary arterial hypertension
R Paulin, J Meloche, S Bonnet
JAK-STAT 2012
RAGE Mediates Accelerated Diabetic Vein Graft Atherosclerosis Induced by Combined Mechanical Stress and AGEs via Synergistic ERK Activation
Y Li, S Liu, Z Zhang, Q Xu, F Xie, J Wang, S Ping, C Li, Z Wang, M Zhang, J Huang, D Chen, L Hu, C Li, TD Oury
PloS one 2012
Natural History of Age-Related Retinal Lesions That Precede AMD in Mice Fed High or Low Glycemic Index Diets
KA Weikel, P Fitzgerald, F Shang, MA Caceres, Q Bian, JT Handa, AW Stitt, A Taylor
Investigative ophthalmology & visual science 2012
Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE
R Romero, T Chaiworapongsa, ZA Savasan, Y Hussein, Z Dong, JP Kusanovic, CJ Kim, SS Hassan
Journal of Maternal-Fetal and Neonatal Medicine 2012
RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity
W Yu, R Liu-Bryan, S Stevens, JK Damanahalli, R Terkeltaub
Atherosclerosis 2012
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling
V Rai, F Toure, S Chitayat, R Pei, F Song, Q Li, J Zhang, R Rosario, R Ramasamy, WJ Chazin, AM Schmidt
Journal of Experimental Medicine 2012
The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes
R Ramasamy, SF Yan, AM Schmidt
Vascular Pharmacology 2012
Resveratrol, wine, and atherosclerosis
K Prasad
International Journal of Angiology 2012
RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer
J DiNorcia, MK Lee, DN Moroziewicz, M Winner, P Suman, F Bao, HE Remotti, YS Zou, SF Yan, W Qiu, GH Su, AM Schmidt, JD Allendorf
Journal of Gastrointestinal Surgery 2011
Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1
V Rai, AY Maldonado, DS Burz, S Reverdatto, SF Yan, AM Schmidt, A Shekhtman
The Journal of biological chemistry 2011
S100A12 in Vascular Smooth Muscle Accelerates Vascular Calcification in Apolipoprotein E–Null Mice by Activating an Osteogenic Gene Regulatory Program
MA Bowman, J Gawdzik, U Bukhari, AN Husain, PT Toth, G Kim, J Earley, EM McNally
Arteriosclerosis, thrombosis, and vascular biology 2011
RAGE-Dependent Activation of the Oncoprotein Pim1 Plays a Critical Role in Systemic Vascular Remodeling Processes
J Meloche, R Paulin, A Courboulin, C Lambert, M Barrier, P Bonnet, M Bisserier, M Roy, MA Sussman, M Agharazii, S Bonnet
Arteriosclerosis, thrombosis, and vascular biology 2011
Molecular mechanisms of diabetic vascular complications
M Kitada, Z Zhang, A Mima, GL King
Journal of Diabetes Investigation 2010
Reduction of PKCβII activity in smooth muscle cells attenuates acute arterial injury
C Huang, JS Chang, Y Xu, Q Li, YS Zou, SF Yan
Atherosclerosis 2010
RAGE Signaling Significantly Impacts Tumorigenesis and Hepatic Tumor Growth in Murine Models of Colorectal Carcinoma
J DiNorcia, DN Moroziewicz, N Ippagunta, MK Lee, M Foster, HZ Rotterdam, F Bao, YS Zhou, SF Yan, J Emond, AM Schmidt, JD Allendorf
Journal of Gastrointestinal Surgery 2010
Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex
N Origlia, C Bonadonna, A Rosellini, E Leznik, O Arancio, SS Yan, L Domenici
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010
Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging
SF Yan, R Ramasamy, AM Schmidt
Biochemical Pharmacology 2010
Alagebrium chloride, a novel advanced glycation end-product cross linkage breaker, inhibits neointimal proliferation in a diabetic rat carotid balloon injury model
JB Kim, BW Song, S Park, KC Hwang, BS Cha, Y Jang, HC Lee, MH Lee
Korean Circulation Journal 2010
RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways
L Shang, R Ananthakrishnan, Q Li, N Quadri, M Abdillahi, Z Zhu, W Qu, R Rosario, F Touré, SF Yan, AM Schmidt, R Ramasamy
PloS one 2010
Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention
ED McNair, CR Wells, AM Qureshi, R Basran, C Pearce, J Orvold, J Devilliers, K Prasad
Clinical Cardiology 2010
Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting
D Aronson, ER Edelman
Reviews in Endocrine and Metabolic Disorders 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Anti-Receptor for Advanced Glycation End Products Therapies as Novel Treatment for Abdominal Aortic Aneurysm
F Zhang, KC Kent, D Yamanouchi, Y Zhang, K Kato, S Tsai, R Nowygrod, AM Schmidt, B Liu
Transactions of the ... Meeting of the American Surgical Association 2009
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
A Bierhaus, PP Nawroth
Diabetologia 2009
Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory response
SF Yan, R Ramasamy, AM Schmidt
Journal of Molecular Medicine 2009
Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy
SJ Yoon, YW Yoon, BK Lee, HM Kwon, KC Hwang, M Kim, W Chang, BK Hong, YH Lee, SJ Park, PK Min, SJ Rim
Experimental & molecular medicine 2009
Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation
L Meng, J Park, Q Cai, L Lanting, MA Reddy, R Natarajan
American journal of physiology. Heart and circulatory physiology 2009
AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis
PM Humpert, IK Lukic, SR Thorpe, S Hofer, EM Awad, M Andrassy, EK Deemer, M Kasper, E Schleicher, M Schwaninger, MA Weigand, PP Nawroth, A Bierhaus
Journal of leukocyte biology 2009
RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction
K Takuma, F Fang, W Zhang, S Yan, E Fukuzaki, H Du, A Sosunov, G McKhann, Y Funatsu, N Nakamichi, T Nagai, H Mizoguchi, D Ibi, O Hori, S Ogawa, DM Stern, K Yamada, SS Yan
Proceedings of the National Academy of Sciences 2009
RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?
SD Yan, A Bierhaus, PP Nawroth, DM Stern
Journal of Alzheimer's disease : JAD 2009
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE
N Origlia, S Capsoni, A Cattaneo, F Fang, O Arancio, SD Yan, L Domenici
Journal of Alzheimer's disease : JAD 2009
The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease
SF Yan, R Ramasamy, AM Schmidt
Expert Reviews in Molecular Medicine 2009
Advanced glycation end products and C-peptide—modulators in diabetic vasculopathy and atherogenesis
D Walcher, N Marx
Seminars in Immunopathology 2009
Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia
M Torreggiani, H Liu, J Wu, F Zheng, W Cai, G Striker, H Vlassara
The American Journal of Pathology 2009
Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
SF Yan, SD Yan, R Ramasamy, AM Schmidt
Annals of Medicine 2009
Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene
AZ Kalea, N Reiniger, H Yang, M Arriero, AM Schmidt, BI Hudson
The FASEB Journal 2009
Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue
SP Baba, OA Barski, Y Ahmed, TE O'Toole, DJ Conklin, A Bhatnagar, S Srivastava
Diabetes 2009
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s disease
L Zhang, R Postina, Y Wang
Cellular and Molecular Life Sciences 2009
Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress
J Chen, M Song, S Yu, P Gao, Y Yu, H Wang, L Huang
Molecular and Cellular Biochemistry 2009
S100A4 and Bone Morphogenetic Protein-2 Codependently Induce Vascular Smooth Muscle Cell Migration via Phospho–Extracellular Signal-Regulated Kinase and Chloride Intracellular Channel 4
E Spiekerkoetter, C Guignabert, V de Jesus Perez, TP Alastalo, JM Powers, L Wang, A Lawrie, N Ambartsumian, AM Schmidt, M Berryman, RH Ashley, M Rabinovitch
Circulation research 2009
RAGE signaling in inflammation and arterial aging.
Lin L, Park S, Lakatta EG
2009
Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients.
McNair ED, Wells CR, Qureshi AM, Basran RS, Pearce C, Orvold J, Devilliers J, Prasad K
International Journal of Angiology 2009
Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
A Soro-Paavonen, AM Watson, J Li, K Paavonen, A Koitka, AC Calkin, D Barit, MT Coughlan, BG Drew, GI Lancaster, M Thomas, JM Forbes, PP Nawroth, A Bierhaus, ME Cooper, KA Jandeleit-Dahm
Diabetes 2008
Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation
R Romero, J Espinoza, S Hassan, F Gotsch, JP Kusanovic, C Avila, O Erez, S Edwin, AM Schmidt
Journal of Perinatal Medicine 2008
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction
N Origlia, M Righi, S Capsoni, A Cattaneo, F Fang, DM Stern, JX Chen, AM Schmidt, O Arancio, SD Yan, L Domenici
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008
RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium
LG Bucciarelli, R Ananthakrishnan, YC Hwang, M Kaneko, F Song, DR Sell, C Strauch, VM Monnier, SF Yan, AM Schmidt, R Ramasamy
Diabetes 2008
Receptor for Advanced Glycation End Products
R Ramasamy, SF Yan, K Herold, R Clynes, AM Schmidt
Annals of the New York Academy of Sciences 2008
Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42
BI Hudson, AZ Kalea, MD Arriero, E Harja, E Boulanger, V D'Agati, AM Schmidt
The Journal of biological chemistry 2008
Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy
YW Yoon, TS Kang, BK Lee, W Chang, KC Hwang, JH Rhee, PK Min, BK Hong, SJ Rim, HM Kwon
Experimental & molecular medicine 2008
Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress
J Qin, R Goswami, S Dawson, G Dawson
Journal of Neuroscience Research 2008
RAGE Mediates Podocyte Injury in Adriamycin-induced Glomerulosclerosis
J Guo, R Ananthakrishnan, W Qu, Y Lu, N Reiniger, S Zeng, W Ma, R Rosario, SF Yan, R Ramasamy, V D'Agati, AM Schmidt
Journal of the American Society of Nephrology : JASN 2008
Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice
MA Reddy, LM Villeneuve, M Wang, L Lanting, R Natarajan
Circulation research 2008
Vascular & Inflammatory Stress Mediate Atherosclerosis via RAGE & its Ligands
Evis Harja, De-xiu Bu, Barry I. Hudson, Jong Sun Chang, Xiaoping Shen, Kellie Hallam, Anastasia Z. Kalea, Yan Lu, Rosa H. Rosario, Sai Oruganti, Zana Nikolla, Dmitri Belov, Evanthia Lalla, Ravichandran Ramasamy, Shi Fang Yan, and Ann Marie Schmidt
Journal of Clinical Investigation 2007
The biology of RAGE and its ligands: Uncovering mechanisms at the heart of diabetes and its complications
SF Yan, GR Barile, V DAgati, SD Yan, R Ramasamy, AM Schmidt
Current Diabetes Reports 2007
RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases
H Koyama, H Yamamoto, Y Nishizawa
Molecular Medicine 2007
Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis
L Carroll, IH Frazer, M Turner, TH Marwick, R Thomas
Arthritis Research & Therapy 2007
Beneficial effects of losartan on vascular injury induced by advanced glycosylation end products and their receptors in spontaneous hypertension rats
WW Zhu, XP Liu, N Wu, TT Zhao, Y Zhao, J Zhang, JH Shao
Molecular and Cellular Biochemistry 2007
Reduced Acute Vascular Injury and Atherosclerosis in Hyperlipidemic Mice Transgenic for Lysozyme
H Liu, F Zheng, Z Li, J Uribarri, B Ren, R Hutter, JR Tunstead, J Badimon, GE Striker, H Vlassara
The American Journal of Pathology 2006
The ligand/RAGE axis: Lighting the fuse and igniting vascular stress
SF Yan, Y Naka, BI Hudson, K Herold, SD Yan, R Ramasamy, AM Schmidt
Current Atherosclerosis Reports 2006
Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms.
Vasdev S, Gill V, Singal PK
Vascular Health and Risk Management 2006
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus, PM Humpert, M Morcos, T Wendt, T Chavakis, B Arnold, DM Stern, PP Nawroth
Journal of Molecular Medicine 2005
Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis
RF Loeser, RR Yammani, CS Carlson, H Chen, A Cole, HJ Im, LS Bursch, SD Yan
Arthritis & Rheumatism 2005
Atherosclerosis and restenosis: Is there a role for rage?
P Nawroth, A Bierhaus, M Marrero, H Yamamoto, DM Stern
Current Diabetes Reports 2005
The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas
Y Yamada, K Ishibashi, K Ishibashi, IA Bhutto, J Tian, GA Lutty, JT Handa
Experimental Eye Research 2005
Serum Levels of Advanced Glycation End Products Are Associated with In-Stent Restenosis in Diabetic Patients
EY Choi, HM Kwon, CW Ahn, GT Lee, B Joung, BK Hong, YW Yoon, D Kim, KH Byun, TS Kang, SJ Yoon, SW Kwon, SJ Lee, JK Park, HS Kim
Yonsei Medical Journal 2005
RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease
BI Hudson, AM Schmidt
Pharmaceutical Research 2004
Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding
G Sorci, F Riuzzi, C Arcuri, I Giambanco, R Donato
Molecular and cellular biology 2004
Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic Psammomys obesus
M Zoltowska, E Delvin, E Ziv, N Peretti, M Chartré, E Levy
Lipids 2004
Advanced Glycation Endproduct Crosslinking in the Cardiovascular System: Potential Therapeutic Target for Cardiovascular Disease
SJ Zieman, DA Kass
Drugs 2004
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment
T Chavakis, A Bierhaus, N Al-Fakhri, D Schneider, S Witte, T Linn, M Nagashima, J Morser, B Arnold, KT Preissner, PP Nawroth
Journal of Experimental Medicine 2003
Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells.
Renard CB, Askari B, Suzuki LA, Kramer F, Bornfeldt KE
Diabetologia 2003

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
36 readers on Mendeley
See more details